Last reviewed · How we verify
Accidental poisoning by lead and its compounds and fumes — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Calcium Disodium Versenate | EDETIC ACID | Medicis | Anti-coagulant | Amyloid beta A4 protein | 1953-01-01 | |
| Bal | DIMERCAPROL | Provepharm Sas | alpha-Adrenergic Agonist [EPC] | 1946-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 1 drug in Accidental poisoning by lead and its compounds and fumes
- Medicis · 1 drug in Accidental poisoning by lead and its compounds and fumes
- Provepharm Sas · 1 drug in Accidental poisoning by lead and its compounds and fumes
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Accidental poisoning by lead and its compounds and fumes:
- Accidental poisoning by lead and its compounds and fumes treatment updates — RSS
- Accidental poisoning by lead and its compounds and fumes treatment updates — Atom
- Accidental poisoning by lead and its compounds and fumes treatment updates — JSON
Cite this brief
Drug Landscape (2026). Accidental poisoning by lead and its compounds and fumes — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/accidental-poisoning-by-lead-and-its-compounds-and-fumes. Accessed 2026-06-10.
Related
- Accidental poisoning by lead and its compounds and fumes full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing